Novavax, Inc. (NVAX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
| Previous Close | 84.65 |
| Open | 81.12 |
| Bid | 0.00 x 1200 |
| Ask | 0.00 x 800 |
| Day's Range | 66.40 - 81.12 |
| 52 Week Range | 66.40 - 331.68 |
| Volume | |
| Avg. Volume | 6,039,073 |
| Market Cap | 6.009B |
| Beta (5Y Monthly) | 1.16 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -14.95 |
| Earnings Date | Feb. 28, 2022 - Mar. 04, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 270.00 |
- Motley Fool
Why Vaccine Stocks Like Moderna and Novavax Tumbled (Again) Today
The bullish case for owning COVID-19 vaccine makers is weakening as much of the world throws in the towel on trying to curb the spread of the coronavirus.
- Motley Fool
1 Green Flag for Novavax in 2022, and 1 Red Flag
Novavax (NASDAQ: NVAX) is arriving more than a year after market leaders Pfizer and Moderna to the coronavirus vaccine finish line. Novavax soared 2,700% in 2020. As of today, Novavax's vaccine has won authorization from more than 30 countries.
- Yahoo Finance Video
COVID-19: The definition of fully vaccinated ‘needs to be changed,’ doctor says
Dr. Owais Durrani, Emergency Medicine Physician, joins Yahoo Finance Live to discuss including the booster shot in definitions of being fully vaccinated, monitoring and testing for potential COVID symptoms, transmissibility in hospitals for non-COVID patients, and the outlook on variant case numbers.
